
Natco Pharma Limited has informed the Exchange regarding a press release dated February 10, 2025, titled "NATCO announces final approval of its ANDA for Bosentan tablets".
Filed with NSE ·

Natco Pharma Limited has informed the Exchange regarding a press release dated February 10, 2025, titled "NATCO announces final approval of its ANDA for Bosentan tablets".
6ix hasn’t read this filing yet.
Follow NATCO Pharma into a list and get an email when it puts out news.
Follow NATCO Pharma